Annette M. Lim

2.9k total citations
52 papers, 565 citations indexed

About

Annette M. Lim is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Annette M. Lim has authored 52 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 18 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Annette M. Lim's work include Cancer Immunotherapy and Biomarkers (19 papers), Nonmelanoma Skin Cancer Studies (18 papers) and Head and Neck Cancer Studies (11 papers). Annette M. Lim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Nonmelanoma Skin Cancer Studies (18 papers) and Head and Neck Cancer Studies (11 papers). Annette M. Lim collaborates with scholars based in Australia, United States and Spain. Annette M. Lim's co-authors include Danny Rischin, Benjamin Solomon, June Corry, Richard J. Young, Grant A. McArthur, Stephen B. Fox, Marnie Collins, Christopher Angel, Richard Fisher and Rodney J. Hicks and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Annette M. Lim

45 papers receiving 560 citations

Peers

Annette M. Lim

ONCOL

OTORH

EPIDE

Ying‐Ju Kuo Taiwan

Loreto Spencer Chile

J R Gosney United Kingdom

Josena K. Stephen United States

Laura Ardighieri Italy

Su-Mi Chung South Korea

Alberto Comino Italy

Hua-Qing Min China

I Ruschenburg Germany

Ying‐Ju Kuo Taiwan

Annette M. Lim

361 ×1.4

ONCOL

134 ×0.7

116 ×0.7

OTORH

129 ×0.9

EPIDE

68 ×0.6

Citations per year, relative to Annette M. Lim Annette M. Lim (= 1×) peers Ying‐Ju Kuo

Countries citing papers authored by Annette M. Lim

Since Specialization

Citations

This map shows the geographic impact of Annette M. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette M. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette M. Lim more than expected).

Fields of papers citing papers by Annette M. Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette M. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette M. Lim. The network helps show where Annette M. Lim may publish in the future.

Co-authorship network of co-authors of Annette M. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Annette M. Lim. A scholar is included among the top collaborators of Annette M. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette M. Lim. Annette M. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lim, Annette M., Benjamin Baker, Christopher Angel, et al.. (2025). Radiological, Pathological, and Surgical Outcomes with Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma in the Deep Sequencing in Cutaneous Squamous Cell Carcinomas (DISCERN) Trial. Cancers. 17(10). 1727–1727.

Hong, Ming, Beatriz Cirauqui, J-P. Machiels, et al.. (2025). 1324MO ASPEN-04: A randomized phase II study of evorpacept in combination with pembrolizumab and chemotherapy in patients with recurrent, unresectable or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 36. S771–S771.

Topp, Monique, Linda Mileshkin, Annette M. Lim, et al.. (2024). Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–2022. Asia-Pacific Journal of Clinical Oncology. 20(6). 731–737.

Long, Georgina V., Robert I. Haddad, Caroline Robert, et al.. (2024). A randomized phase 2 trial of the IO102-IO103 (IDO and PD-L1) cancer vaccine plus pembrolizumab as neoadjuvant/adjuvant treatment of patients with solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2701–TPS2701. 2 indexed citations

Lim, Annette M., Christopher Angel, Richard J. Young, et al.. (2024). A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors. Cancers. 16(8). 1452–1452. 1 indexed citations

Lim, Annette M., et al.. (2024). Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy. Cancer Imaging. 24(1). 37–37. 3 indexed citations

Lim, Annette M., Mathias Bressel, Jenny Lee, et al.. (2024). Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study. The Medical Journal of Australia. 220(2). 80–90. 8 indexed citations

Lim, Annette M., et al.. (2024). Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma. Drugs & Aging. 41(3). 271–281. 3 indexed citations

Lim, Annette M., et al.. (2022). Immunotherapy to Avoid Orbital Exenteration in Patients With Cutaneous Squamous Cell Carcinoma. Frontiers in Oncology. 11. 796197–796197. 17 indexed citations

10.

Goh, Michelle, et al.. (2022). The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma. American Journal of Clinical Dermatology. 24(1). 25–40. 11 indexed citations

11.

Jacques, Angela, et al.. (2021). Clinicopathological characteristics and clinical morbidity in high‐risk head and neck cutaneous squamous cell carcinoma patients in Western Australia. Internal Medicine Journal. 52(6). 944–951. 2 indexed citations

12.

Wong, Nicholas C., Michael E. Clark, Stephen Q. Wong, et al.. (2021). Author Correction: Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer. Scientific Reports. 11(1). 15616–15616. 1 indexed citations

13.

Tourneau, C. Le, Danny Rischin, Stefanie L. Groenland, et al.. (2020). 1O Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 31. S1–S1. 3 indexed citations

14.

Horvath, Lisa G., Jayesh Desai, Shahneen Sandhu, et al.. (2017). Preliminary results from a subset of patients (pts) with advanced head and neck squamous carcinoma (HNSCC) in a dose-escalation and dose-expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb). Annals of Oncology. 28. v129–v130. 3 indexed citations

15.

Lim, Annette M., Nicholas C. Wong, Ruth Pidsley, et al.. (2016). Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas. Clinical Epigenetics. 8(1). 74–74. 10 indexed citations

16.

Lim, Annette M., Benjamin Solomon, & Danny Rischin. (2015). Molecular insights influencing the management of head and neck cancers. Cancer Forum. 39(1). 29.

17.

Lim, Annette M., June Corry, Marnie Collins, et al.. (2013). A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma. Oral Oncology. 49(5). 468–474. 27 indexed citations

18.

Lim, Annette M. & Simon Richards. (2012). Benign palmar schwannoma – a rare case in a handball player. BMJ Case Reports. 2012. bcr0120125532–bcr0120125532. 1 indexed citations

19.

Lim, Annette M., Richard J. Young, Marnie Collins, et al.. (2012). Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma. Oral Oncology. 48(8). 698–702. 7 indexed citations

20.

Young, Richard J., Danny Rischin, Richard Fisher, et al.. (2011). Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 20(6). 1230–1237. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact